India, Oct. 24 -- Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) reported earnings for nine months that Dropped, from the same period last year The company's earnings came in at RMB617.318 million, o... Read More
India, Oct. 24 -- Roche (RHHBY) announced new late-breaking data from the ongoing Phase III IMAgINATION study showing that its investigational therapy sefaxersen delivered a statistically significant ... Read More
India, Oct. 24 -- Glarun Technology Co.,Ltd (600562.SS) reported a profit for nine months that Dropped, from the same period last year The company's earnings came in at RMB293.851 million, or RMB0.24... Read More
India, Oct. 24 -- Tasly Pharmaceutical Group Co., Ltd (600535.SS) released earnings for its nine months that Increased, from last year The company's bottom line came in at RMB1.102 billion, or RMB0.7... Read More
India, Oct. 23 -- Motley Crue has announced an eight-show Las Vegas residency, "Carnival Of Sins In Sin City," in 2027. The residency is set to take place at The Colosseum at Caesars Palace from Marc... Read More
India, Oct. 23 -- Bollore SE (BOP.SG,BOL.PA) reported third-quarter 2026 revenue of 937 million euros, up 49% from 630 million euros a year earlier. The reported revenue included a negative 17 million... Read More
India, Oct. 23 -- Foremost Clean Energy Ltd. (FMST) agreed to sell a 31% interest in its GR and Blackwing properties to Denison Mines Corp. The deal includes forming two exploration joint ventures an... Read More
India, Oct. 23 -- Bristol Myers Squibb (BMY) presented interim results from the Phase 1 Breakfree-2 study of investigational zolacabtagene autoleucel (zola-cel) in patients with highly active relapsin... Read More
India, Oct. 23 -- Stocks moved mostly lower in early trading on Friday, extending the sell-off seen over the course of the previous session. Selling pressure has waned over the course of the session, ... Read More
India, Oct. 23 -- Bristol Myers Squibb (BMY) reported interim Phase 1 Breakfree-2 study results for investigational CAR T-cell therapy zolacabtagene autoleucel (zola-cel) in 66 patients with highly ac... Read More